Study finds remdesivir, hydroxychloroquine have 'little' impact on mortality in COVID-19 patients

A clinical trial conducted by the World Health Organization found that Gilead Sciences Inc.'s remdesivir, hydroxychloroquine, AbbVie's...
Source: Reuters: Health - Category: Consumer Health News Source Type: news